Cost effectiveness of the cancer prevention program for carriers of the BRCA1/2 mutation.
Ramos Marcelo Cristiano de Azevedo, Folgueira Maria Aparecida Azevedo Koike, Maistro Simone, +5 more·Revista de saude publica
OBJECTIVE: To analyze the cost effectiveness of the diagnostic program for the germline mutation in BRCA1/2 genes and of preventative strategies for the relatives of patients diagnosed with ovarian cancer associated with this mutation. METHODS: The study analyzed the cost effectiveness by developing an analysis of the…